Summary 213 representing across race/ethnic subgroups when designing trials from a populationwide perspective. Lastly, in (Chapter 4), we sum up the present situation on HFrEF trial generalizability and discuss future perspectives toward optimizing generalizability in trials.
RkJQdWJsaXNoZXIy MjY0ODMw